Alto Neuroscience (ANRO) Institutional Ownership

During the previous two years, 49 institutional investors and hedge funds held shares of Alto Neuroscience. The most heavily invested institutionals were FMR LLC ($27.03M), RA Capital Management L.P. ($23.74M), Jennison Associates LLC ($9.52M), Vanguard Group Inc. ($8.23M), Point72 Asset Management L.P. ($7.16M), Geode Capital Management LLC ($5.38M), and Artal Group S.A. ($5.37M).Learn more on ANRO's institutional investors.

Of the 46 institutional investors that purchased Alto Neuroscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.39M), Marshall Wace LLP ($837.37K), Jennison Associates LLC ($829.21K), Point72 Asset Management L.P. ($714.46K), Price T Rowe Associates Inc. MD ($673.92K), Franklin Resources Inc. ($595.67K), and Vanguard Group Inc. ($536.33K).

Institutional investors have bought a total of 10,336,103 shares in the last 24 months. This purchase volume represents approximately $99.78M in transactions.

Of the 11 institutional investors that sold Alto Neuroscience stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alkeon Capital Management LLC ($457.80K), Board of Trustees of The Leland Stanford Junior University ($264.27K), Point72 Asset Management L.P. ($147.31K), Nuveen Asset Management LLC ($61.31K), Franklin Resources Inc. ($58.10K), Charles Schwab Investment Management Inc. ($32.14K), and Bowie Capital Management LLC ($23.70K).

Institutional investors have sold a total of 1,074,287 shares in the last 24 months. This volume of shares sold represents approximately $7.71M in transactions.